Abstract
In search for genetic causes of hypertension, Siffert and coworkers[1]have recently identified a single nucleotide polymorphism in a gene encoding for pertussis-toxin (PTX) sensitive Gi-proteins. The authors had noted that a subgroup of patients with “essential hypertension” displayed in their blood platelets high activity of the Na+/H+exchanger that could be traced back to enhanced signal transduction in this ubiquitously expressed ion transport system. Signal transduction between receptors and effectors was also enhance.d in immortalized cell lines from these individuals and PTX-sensitive Gi-proteins were likely to be involved [2 3]. The altered activity of Gi-proteins was related to a thymine-for-cytosine polymorphism (C825Tpolymorphism) in exon 10 of the gene encoding for the ß3-subunit of the heterotrimeric complexes(GNB3)[3]. The 825T-allele is associated with alternative splicing of exon 9 resulting in an additional Gß3-s-subunit which is shorter by 41 amino acids but more active than the full-size G[33-subunit [3]. Clinically, the 825T-allele was first associated with essential hypertension [3[4][5][6][7][8]though recently several other clinical conditions have also been associated (see table 1). This is not surprising if one considers the central role of heterotrimeric G-proteins in signal transduction. So far, the enhanced activity of the splice variant Gß3-s has been demonstrated mostly in blood cells, i.e. in immortalized lymphoblasts or freshly isolated neutrophils [26 27]. Since the 825T-allele is present in all cells, we have studied the putative association between 825T-allele status and the activity of signal transduction in human atrial myocytes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erberl R, Shamrma AM, Ritz E, Wichmann H-E, Jakobs K-H, Horsthemke B. Association of a human G-protein 33 subunit variant with hypertension. Nature Genetics 1998;18:45–8.
Rosskopf D, Schröder K-J, Siffert W. Role of sodium-hydrogen exchange in the proliferation of immortalized lymphoblasts from patients with essential hypertension and normotensive subjects. Cardiovasc Res 1995;29:254–59.
Siffert W, Düsing R. Sodium-proton exchange and primary hypertension. Hypertension 1995;26:649–55.
Benjafield AV, Jeyasingam CL, Nyholt DR, Griffiths LR, Morris BJ. G-Protein f33 subunit(GNB3)variant in causation of essential hypertension. Hypertension 1998;32:1094–7.
Hegele RA, Harris SB, Hanley AJG, Cao H, Zinman B. G protein 133 subunit gene variant and blood pressure variation in Canadian Oji-Cree. Hypertension 1998;32:688–92.
Schunkert H, Hense HW, Döring A, Riegger GAI, Siffert W. Association between a polymorphism in the G protein (33 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension 1998;32:510–3.
Beige J, Hohenbleicher H, Distler A, Sharma AM. G-Protein 133 subunit C825T variant and ambulatory blood pressure in essential hypertension. Hypertension 1999;33:1049–51.
Dong Y, Zhu H, Sagnella GA, Carter ND, Cook DG, Cappuccio FP. Association between the C825T polymorphism of the G protein (33-subunit gene and hypertension in blacks. Hypertension 1999;34:1193–6.
Hengstenberg Ch, Schunkert H, Mayer B, Döring A., Loewel H. Hense HW, Fischer M, Riegger GAJ, Holmer SR. Association between a polymorphism in the G protein f33 subunit gene(GNB3)with arterial hypertension but not myocardial infarction. Cardiovasc Res 2001;49:820–7.
Jacobi J, Hilgers KF, Schlaich MP, Siffert W, Schmieder RE. 825T allele of the G-protein 133 subunit gene(GNB3) isassociated with impaired left ventricular diastolic filling in essential hypertension. J Hypertens 1999;17:1457–62.
Poch E, Gonzalez D, Gomez-Angelats E, Enjuto M, Pare JC, Rivera F, de La Sierra A. G-Protein 133 subunit gene variant and left ventricular hypertrophy in essentual hypertension. Hypertension 2000;35:214–8.
Morrison AC, Doris PA, Folsom AR, Nieto FJ, Boerwinkle E. G-protein (33 subunit and aadducin polymorphisms and risk of subclinical and clinical stroke. Stroke 2001;32:822–9.
Naber CK, Husing J, Wolfliard U, Erbel R, Siffert W. Interaction of the ACE D allele and the GNB3 825T allele in myocardial infarction. Hypertension 2000;36:986–9.
Hegele RA, Anderson C, Young TK, Connelly PW. G-protein 133 subunit gene splice variant and body fat distribution in Nunavut Inuit. Genome Res 1999;9:972–7.
Siffert W, Forster P, Jockel KH, Mvere DA, Brinkmann B, Naber C, Crookes R, Du P Heyns A, Epplen IT, Fridey J, Freedman BI, Muller N, Stolke D, Sharma AM, Al Moutaery K, Grosse-Wilde H, Buerbaum B, Ehrlich T, Ahmad HR, Horsthemke B, Du Toit ED, Tiilikainen A, Ge J, Wang Y, Rosskopf D, et al. Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 1999a;10:1921–30.
Siffert W, Naber C. Walla M, Ritz E. G protein beta3 subunit 825T allele and its potential association with obesity in hypertensive individuals. J Hypertens 1999b;17:1095–8.
Zeltner R, Delles C, Schneider M, Siffert W, Schmieder RE. G-Proteinß3subunit gene(GNB3)825T allele is associated with enhanced renal perfusion in early hypertension. Hypertension 2001;37:882–6.
Hocher B, Slowinski T, Stolze T, Pleschka A, Neumayer HH, Halle H. Association of maternal G protein f33 subunit 825T allele with low birth weight. Lancet 2000;355;1241–2.
Gutersohn A, Naber C, Müller N, Erbel R, Siffert W. G Protein ß3 subunit 825 TT genotype and post-pregnancy weight retention. Lancet 2000;355:1240–1.
Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. C825T Polymorphism of the G protein ß3-subunit and antihypertensive response to a thiazide diuretic. Hypertension 2001;37:739–43.
Zill P, Baghai TC, Zwanzger P, Schule C, Minov C, Riedel M, Neumeier K, Rupprecht R, Bondy B. Evidence for an association between a G-protein 33-gene variant with depression and response to antidepressant treatment. Neuroreport 2000;11:1893–7.
Baumgart D, Naber C, Haude M, Oldenburg O, Erbel R, Heusch G, Siffert W. G Protein ß3 825T allele and enhanced coronary vasoconstriction on a2-adrenoceptor activation. Cire Res 1999;85: 965–9.
Naber C, Hermann BL, Vietzke D, Altmann C, Haude M, Mann K, Rosskopf D, Siffert W. Enhanced epinephrine-induced platelet aggregation in individuals carrying the G protein ß3 subunit 825T allele. FEBS Lett 2000;484:199–201.
Grossmann M, Dobrev D, Siffert W, Kirch W. Heterogeneity of hand vein responses to acetylcholine is not associated with polymorphisms in the G-protein ß3-subunit (C825T) and endothelial nitric oxide synthase (G894T) genes but with serum LDL cholesterol. Pharmacogenetics 2001;11:307–16.
Schafers RF, Nurnberger J, Rutz A, Siffert W, Wenzel RR, Mitchell A, Philipp T, Michel MC. Haemodynamic characterization of young normotensive men carrying the 825T-allele of the G-protein 133 subunit. Pharmacogenetics 2001;11:461–70.
Siffert W, Rosskopf D, Moritz A, Wieland T, Kaldenberg-Stasch S, Ketler N, Hartung K, Beckmann S, Jakobs K-H. Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J Clin Invest 1995;96:759–66.
Virchow S, Ansorge N, Rubben H, Siffert G, Siffert W. Enhanced fMLP-stimulated chemotaxis in human neutrophils from individuals carrying the G protein 133 subunit 825 T-allele. FEBS Lett 1998;436:155–8.
Krapivinsky G, Krapivinsky L, Wickman K, Clapham DE. G(3y binds directly to the G protein-gated K+channel, IK ACh. J Biol Chem 1995;270:29059–62.
Yamada M, Inanobe A, Kurachi Y. G protein regulation of potassium ion channels. Pharmacol Rev 1998;50:723–57.
Farfel Z, Bourne HR, liri T. The expanding spectrum of G protein diseases. N Engl J Med 1999;340:1012–20.
Dobrev D, Wettwer E, Himmel HM, Kortner A, Kuhlisch E, Schüler S, Siffert W, Ravens U. G-protein 133-subunit 825T-allele is associated with enhanced human atrial inward rectifier potassium currents. Circulation 2000;102: 692–7.
liri T, Farfel Z, Bourne HR. G-protein diseases furnish a model for the turn-on switch. Nature 1998;394:35–8.
Neubig RR, Gantzos RD, Brasier RS. Agonist and antagonist binding to a2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry. Mol Pharmacol 1985;28:475–86.
Milligan G. The stoichiometry of expression of protein components of the stimulatory adenylyl cyclase cascade and the regulation of information transfer. Cell Signal 1996;8:8796.
Böhm M, Ungerer M, Erdmann E. Beta adrenoceptors and m-cholinoceptors in myocardium of hearts with coronary artery disease or idiopathic dilated cardiomyopathy removed at cardiac transplantation. Am J Cardiol 1990;66:880–2.
Bosch RF, Zeng XR, Grammer JB, Popovic K., Mewis C, Kühlkamp V.. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 1999;44:121–31.
Van Wagoner DR, Pond AL, McCarthy PM, Trimmer JS, Nerbonne JM. Outward K+current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 1997;80:772–81.
Brundel BJJM, Van Gelder IC, Henning RH, Tieleman RG, Tuinenburg AE, Wietses M, Grandjean JG, Van Gilst WH, Crijns JGM. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 2001;103:684–90.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ravens, U., Wettwer, E., Christ, T., Dobrev, D. (2002). G-Protein β3-Subunit Polymorphism and Atrial Fibrillation. In: Doevendans, P.A., Kääb, S. (eds) Cardiovascular Genomics: New Pathophysiological Concepts. Developments in Cardiovascular Medicine, vol 242. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1005-5_18
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1005-5_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5347-8
Online ISBN: 978-1-4615-1005-5
eBook Packages: Springer Book Archive